At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
About the role
CI is Connecticut’s strategic venture capital arm and one of the most active early-stage investors on the eastern seaboard. CI has a portfolio of 250+ companies across 5 equity funds and a 1 venture debt fund. We have $550 million in assets under management, and our venture portfolio employs 4,000 jobs. In a typical year, we deploy $50 million and write between 60-80 checks. We review 750 companies per year and invite over 100 founders in to pitch us each year.
What they're looking for
- PhD strongly preferred, MD/PhD highly desirable. Candidates with a Master’s degree in business or science will be considered, doctoral-level training is a significant advantage
- Knowledge of the healthcare and life sciences landscape, including therapeutics, biotechnology, medtech, diagnostics, and digital health
- You have a network or interest in building a network within the lifesciences venture capital ecosystem, including relationships with relevant academics institutions, VCs, incubators, and accelerators
- Experience in conducting market, product, competitive and valuation analysis
- Startup/growth experience in a venture-backed company is highly valued, especially serving as a founder
- Experience in investment origination, due diligence, deal execution, and portfolio company management preferred
More about this role
CI is Connecticut’s strategic venture capital arm and one of the most active early-stage investors on the eastern seaboard. CI has a portfolio of 250+ companies across 5 equity funds and a 1 venture debt fund. We have $550 million in assets under management, and our venture portfolio employs 4,000 jobs. In a typical year, we deploy $50 million and write between 60-80 checks. We review 750 companies per year and invite over 100 founders in to pitch us each year. We add 30 new companies to our portfolio annually, and we also invest as an LP in Connecticut-based venture capital funds.
We measure success through both financial returns and economic impact, including job creation. Over the past decade, CI has generated more than $400 million in returns and cumulatively, our portfolio companies have raised over $8 billion.
- Fiscal 2026 was our best year on record. We generated $76.1 million in cash proceeds from all investment activities. Most of those proceeds came from our strong New Haven bioscience sector. In FY26 actuals, we invested $59.3 million into 75 early-stage companies and venture funds, and those deals pulled an additional $1.2 billion of outside capital into the state.
-...
Browse similar: Venture capital jobs